BACKGROUND: Obesity and fast weight loss in the postoperative period of bariatric surgery increase significantly the risk of cholelithiasis. Moreover, emerging evidence has pointed out the role of bile acids as possible metabolism and weight loss enhancers. This study aims to analyze the influence of cholecystectomy (CL) concomitant with bariatric surgery on weight loss, metabolic repercussions, and postoperative morbidity. STUDY DESIGN: Retrospective cohort study. A total of 363 medical records were analyzed between 2002 and 2017, with 255 patients divided into four groups: with concomitant CL: sleeve gastrectomy (SG + CL group) and Roux-en-Y gastric bypass (GB + CL group); without concomitant CL: sleeve gastrectomy (SG group) and RYGB (GB group). RESULTS: CL concomitant with bariatric surgery is not related to worse long-term metabolic outcomes when compared to isolated bariatric surgery. In the postoperative follow-up of the isolated bariatric surgeries, 18 (16.5%) patients underwent cholecystectomy. There was no statistical difference between the groups regarding post-surgical complications. CONCLUSION: CL did not lead to worse metabolic outcomes and was also not related to a higher incidence of postoperative complications. Cholelithiasis and cholecystitis are important concerns in the postoperative period of bariatric surgery and a careful evaluation of the concomitant procedure should be performed.
BACKGROUND: Obesity and fast weight loss in the postoperative period of bariatric surgery increase significantly the risk of cholelithiasis. Moreover, emerging evidence has pointed out the role of bile acids as possible metabolism and weight loss enhancers. This study aims to analyze the influence of cholecystectomy (CL) concomitant with bariatric surgery on weight loss, metabolic repercussions, and postoperative morbidity. STUDY DESIGN: Retrospective cohort study. A total of 363 medical records were analyzed between 2002 and 2017, with 255 patients divided into four groups: with concomitant CL: sleeve gastrectomy (SG + CL group) and Roux-en-Y gastric bypass (GB + CL group); without concomitant CL: sleeve gastrectomy (SG group) and RYGB (GB group). RESULTS: CL concomitant with bariatric surgery is not related to worse long-term metabolic outcomes when compared to isolated bariatric surgery. In the postoperative follow-up of the isolated bariatric surgeries, 18 (16.5%) patients underwent cholecystectomy. There was no statistical difference between the groups regarding post-surgical complications. CONCLUSION: CL did not lead to worse metabolic outcomes and was also not related to a higher incidence of postoperative complications. Cholelithiasis and cholecystitis are important concerns in the postoperative period of bariatric surgery and a careful evaluation of the concomitant procedure should be performed.
Authors: Robert M Cunningham; Katherine T Jones; Jason E Kuhn; James T Dove; Ryan D Horsley; Mustapha Daouadi; Jon D Gabrielsen; Anthony T Petrick; David M Parker Journal: Obes Surg Date: 2020-11-23 Impact factor: 4.129
Authors: Álvaro A B Ferraz; Vladimir C T de Sá; Fernando Santa-Cruz; Luciana T Siqueira; Lyz B Silva; Josemberg M Campos Journal: Surg Obes Relat Dis Date: 2019-03-20 Impact factor: 4.734
Authors: Josemberg M Campos; Daniel C Lins; Lyz B Silva; José Guido C Araujo-Junior; Jorge L M Zeve; Álvaro A B Ferraz Journal: Arq Bras Cir Dig Date: 2013
Authors: Víctor Cortés; Ludwig Amigo; Silvana Zanlungo; José Galgani; Fermín Robledo; Marco Arrese; Francisco Bozinovic; Flavio Nervi Journal: PLoS One Date: 2015-03-04 Impact factor: 3.240
Authors: Carla Barbosa Nonino; Bruno Affonso Parenti de Oliveira; Raoana Cássia Paixão Chaves; Luciana Tabajara Parreiras E Silva; Marcela Augusta de Souza Pinhel; Flávia de Campos Ferreira; Gabriela da Costa Rocha; Simara Paganini Donadelli; Julio Sergio Marchini; Wilson Salgado-Junior; Carolina Ferreira Nicoletti Journal: Arq Bras Cir Dig Date: 2019-10-21